相关实验视频

Updated: Jul 17, 2025

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

α5-nAChR/STAT3/CD47轴有助于尼古丁相关的肺腺癌进展和免疫逃逸

Guiyu Kang^1,2, Yang Jiao³, Pan Pan¹

¹Research Center of Basic Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, China.

|September 8, 2023

概括

α5-尼古丁性乙胆受体 (α5-nAChR) 和CD47通路促进肺癌的进展和免疫抑制. 针对这一轴可能为肺腺癌 (LUAD) 提供新的免疫治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

CHRNΑ5基因编码了α5-尼古丁性乙胆受体 (α5-nAChR),与肺癌和尼古丁成有关.
吸烟会影响巨细胞的免疫抑制,而CD47是主要的细胞检查点和癌症治疗点.
在肺癌中α5-nAChR和CD47之间的相互作用在很大程度上仍未被探索.

研究的目的:

研究肺腺癌 (LUAD) 中α5-nAChR和CD47之间的关系.
阐明α5-nAChR/STAT3/CD47信号轴在LUAD进展和免疫逃避中的作用.

主要方法:

在体内和体外研究中,研究了在LUAD中的α5-nAChR表达,STAT3信号和CD47表达.
分析α5-nAChR,STAT3,CD47,吸烟状态和LUAD预后之间的相关性.
评估α5-nAChR和CD47下调对LUAD细胞行为和巨细胞灭菌的影响.
在异种移植瘤生长和转移模型中对α5-nAChR/CD47轴的评估.

主要成果:

在LUAD中,α5-nAChR表达通过STAT3信号传递调解了CD47表达.
α5-nAChR表达与STAT3,CD47,吸烟状况和LUAD预后不佳正相关.
降低α5-nAChR和/或CD47的下调降低了LUAD细胞的增殖,迁移,入侵,干细胞和IL-10,同时增加了TNF-α和巨细胞灭菌.
在体内,α5-nAChR/CD47轴促进了瘤生长和转移.

结论:

α5-nAChR/STAT3/CD47轴驱动肺癌的进展和免疫逃生.
这个轴代表了LUAD免疫治疗的潜在治疗标.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...